GB0819633D0 - Composition - Google Patents

Composition

Info

Publication number
GB0819633D0
GB0819633D0 GBGB0819633.9A GB0819633A GB0819633D0 GB 0819633 D0 GB0819633 D0 GB 0819633D0 GB 0819633 A GB0819633 A GB 0819633A GB 0819633 D0 GB0819633 D0 GB 0819633D0
Authority
GB
United Kingdom
Prior art keywords
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0819633.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0819633.9A priority Critical patent/GB0819633D0/en
Publication of GB0819633D0 publication Critical patent/GB0819633D0/en
Priority to HRP20240226TT priority patent/HRP20240226T1/hr
Priority to JP2011532725A priority patent/JP5676458B2/ja
Priority to PCT/GB2009/051439 priority patent/WO2010046715A1/en
Priority to FIEP18209661.0T priority patent/FI3501534T3/fi
Priority to KR1020167035443A priority patent/KR20170000390A/ko
Priority to CN2009801480003A priority patent/CN102245202A/zh
Priority to NZ601538A priority patent/NZ601538A/en
Priority to PL18209661.0T priority patent/PL3501534T3/pl
Priority to CA2741619A priority patent/CA2741619A1/en
Priority to PT182096610T priority patent/PT3501534T/pt
Priority to DK18209661.0T priority patent/DK3501534T5/da
Priority to HUE18209661A priority patent/HUE065348T2/hu
Priority to NZ592444A priority patent/NZ592444A/xx
Priority to LTEP18209661.0T priority patent/LT3501534T/lt
Priority to AU2009306114A priority patent/AU2009306114B2/en
Priority to ES18209661T priority patent/ES2970878T3/es
Priority to EP09753188.3A priority patent/EP2355845B1/en
Priority to KR1020197002691A priority patent/KR20190011836A/ko
Priority to CN201510119007.XA priority patent/CN105412920A/zh
Priority to MX2011004322A priority patent/MX2011004322A/es
Priority to EP18209661.0A priority patent/EP3501534B1/en
Priority to KR1020117011885A priority patent/KR20110092282A/ko
Priority to US13/125,957 priority patent/US20120052092A1/en
Priority to RU2011120706/10A priority patent/RU2559528C2/ru
Priority to SI200932190T priority patent/SI3501534T1/sl
Priority to BRPI0919926A priority patent/BRPI0919926A2/pt
Priority to CO11055224A priority patent/CO6382140A2/es
Priority to JP2014261910A priority patent/JP6076326B2/ja
Priority to AU2015275311A priority patent/AU2015275311B2/en
Priority to AU2017245320A priority patent/AU2017245320B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0819633.9A 2008-10-25 2008-10-25 Composition Ceased GB0819633D0 (en)

Priority Applications (31)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition
BRPI0919926A BRPI0919926A2 (pt) 2008-10-25 2009-10-26 composição de vacina que compreendem uma proteína de ligação do fator h mutada
LTEP18209661.0T LT3501534T (lt) 2008-10-25 2009-10-26 Vakcinos kompozicijos, apimančios mutuotą, faktorių h surišantį baltymą
AU2009306114A AU2009306114B2 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor H binding protein
PCT/GB2009/051439 WO2010046715A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
FIEP18209661.0T FI3501534T3 (fi) 2008-10-25 2009-10-26 Rokotekoostumuksia, jotka käsittävät mutatoitua tekijä h:ta sitovaa proteiinia
KR1020167035443A KR20170000390A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
CN2009801480003A CN102245202A (zh) 2008-10-25 2009-10-26 含有突变型h因子结合蛋白的疫苗组合物
NZ601538A NZ601538A (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
PL18209661.0T PL3501534T3 (pl) 2008-10-25 2009-10-26 Kompozycje szczepionkowe zawierające zmutowane białko wiążące czynnik h
CA2741619A CA2741619A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
PT182096610T PT3501534T (pt) 2008-10-25 2009-10-26 Composições de vacina que compreendem uma proteína de ligação de fator h mutada
DK18209661.0T DK3501534T5 (da) 2008-10-25 2009-10-26 Vaccinesammensætninger omfattende en muteret faktor h-bindende protein
HUE18209661A HUE065348T2 (hu) 2008-10-25 2009-10-26 Egy mutált H-faktor-kötõ fehérjét tartalmazó vakcinakészítmények
NZ592444A NZ592444A (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
HRP20240226TT HRP20240226T1 (hr) 2008-10-25 2009-10-26 Pripravci cjepiva koji sadrže protein vezivanja mutiranog faktora h
ES18209661T ES2970878T3 (es) 2008-10-25 2009-10-26 Composiciones de vacuna que comprenden una proteína de unión al factor H mutada
CN201510119007.XA CN105412920A (zh) 2008-10-25 2009-10-26 含有突变型ｈ因子结合蛋白的疫苗组合物
JP2011532725A JP5676458B2 (ja) 2008-10-25 2009-10-26 変異ｈ因子結合タンパク質を含むワクチン組成物
KR1020197002691A KR20190011836A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
EP09753188.3A EP2355845B1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
MX2011004322A MX2011004322A (es) 2008-10-25 2009-10-26 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada.
EP18209661.0A EP3501534B1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
KR1020117011885A KR20110092282A (ko) 2008-10-25 2009-10-26 돌연변이 인자 ｈ 결합 단백질을 포함하는 백신 조성물
US13/125,957 US20120052092A1 (en) 2008-10-25 2009-10-26 Vaccine compositions comprising a mutated factor h binding protein
RU2011120706/10A RU2559528C2 (ru) 2008-10-25 2009-10-26 КОМПОЗИЦИИ ВАКЦИН ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ИЛИ ЗАБОЛЕВАНИЯ, ВЫЗЫВАЕМЫХ Neisseria meningitides И/ИЛИ Neisseria gonorrhoeae, СОДЕРЖАЩИЕ МУТИРОВАННЫЙ БЕЛОК, СВЯЗЫВАЮЩИЙ ФАКТОР Н
SI200932190T SI3501534T1 (sl) 2008-10-25 2009-10-26 Cepivni sestavki, ki obsegajo mutiran vezavni protein faktorja h
CO11055224A CO6382140A2 (es) 2008-10-25 2011-05-05 Composiciones de vacuna que comprenden una proteina de enlace del factor h mutada
JP2014261910A JP6076326B2 (ja) 2008-10-25 2014-12-25 変異ｈ因子結合タンパク質を含むワクチン組成物
AU2015275311A AU2015275311B2 (en) 2008-10-25 2015-12-23 Vaccine compositions comprising a mutated factor h binding protein
AU2017245320A AU2017245320B2 (en) 2008-10-25 2017-10-10 Vaccine compositions comprising a mutated factor h binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0819633.9A GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Publications (1)

Publication Number Publication Date
GB0819633D0 true GB0819633D0 (en) 2008-12-03

Family

ID=40133849

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0819633.9A Ceased GB0819633D0 (en) 2008-10-25 2008-10-25 Composition

Country Status (23)

Country Link
US (1) US20120052092A1 (enExample)
EP (2) EP3501534B1 (enExample)
JP (2) JP5676458B2 (enExample)
KR (3) KR20170000390A (enExample)
CN (2) CN102245202A (enExample)
AU (1) AU2009306114B2 (enExample)
BR (1) BRPI0919926A2 (enExample)
CA (1) CA2741619A1 (enExample)
CO (1) CO6382140A2 (enExample)
DK (1) DK3501534T5 (enExample)
ES (1) ES2970878T3 (enExample)
FI (1) FI3501534T3 (enExample)
GB (1) GB0819633D0 (enExample)
HR (1) HRP20240226T1 (enExample)
HU (1) HUE065348T2 (enExample)
LT (1) LT3501534T (enExample)
MX (1) MX2011004322A (enExample)
NZ (2) NZ592444A (enExample)
PL (1) PL3501534T3 (enExample)
PT (1) PT3501534T (enExample)
RU (1) RU2559528C2 (enExample)
SI (1) SI3501534T1 (enExample)
WO (1) WO2010046715A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2261339B1 (en) 1998-05-01 2017-03-22 GlaxoSmithKline Biologicals SA Neisseria meningitidis antigens and compositions
DK2270173T3 (en) 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
DK1801219T3 (en) 1999-10-29 2015-12-07 Glaxosmithkline Biolog Sa Neisseriale antigenic peptides.
EP2270031A3 (en) 2000-02-28 2011-02-16 Novartis Vaccines and Diagnostics S.r.l. Heterologous expression of neisserial proteins
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
AU2003274511B2 (en) 2002-10-11 2009-06-04 Glaxosmithkline Biologicals S.A. Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0408977D0 (en) 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
US9579372B2 (en) 2008-02-21 2017-02-28 Glaxosmithkline Biologicals Sa Meningococcal fHBP polypeptides
EP2265640B1 (en) 2008-03-10 2015-11-04 Children's Hospital & Research Center at Oakland Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
BRPI1009828A2 (pt) 2009-03-24 2019-03-12 Novartis Ag adjuvante de proteína de ligação de fator h meningocócica
AU2010242905B2 (en) 2009-04-30 2014-10-23 Children's Hospital & Research Center At Oakland Chimeric factor H binding proteins (fHbp) and methods of use
BR112012010531A2 (pt) * 2009-10-27 2019-09-24 Novartis Ag "polipeptídeos de modificação meningocócica fhbp"
BR112012022669A2 (pt) * 2010-03-10 2017-02-14 Glaxosmithkline Biologicals Sa composição imunogênica, método de tratamento ou prevenção de infecção ou doença, uso de um antígeno, kit, métodos para a fabricação de uma composição imunogênica e para melhorar uma vacina.
BR112012024348B1 (pt) 2010-03-30 2022-11-08 Children's Hospital & Research Center At Oakland Composição imunogênica, seu uso, proteína de ligação ao fator h de ocorrência não natural, e célula bacteriana geneticamente modificada
US10478483B2 (en) 2010-06-25 2019-11-19 Glaxosmithkline Biologicals Sa Combinations of meningococcal factor H binding proteins
CA2861946A1 (en) 2012-02-02 2013-08-08 Novartis Ag Promoters for increased protein expression in meningococcus
RU2644340C2 (ru) 2012-06-14 2018-02-08 Новартис Аг Вакцины для менингококка серогруппы х
HK1205138A1 (en) 2012-07-27 2015-12-11 Institut National De La Santé Et De La Recherche Médicale (Inserm) Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
WO2014140562A1 (en) * 2013-03-14 2014-09-18 Isis Innovation Limited Immunogenic composition to neisseria
KR20160034401A (ko) 2013-08-02 2016-03-29 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 비-천연적으로 발생하는 인자 h 결합 단백질(fhbp) 및 이의 사용 방법
AU2015222121B2 (en) 2014-02-28 2018-01-18 Glaxosmithkline Biologicals Sa Modified meningococcal fHbp polypeptides
CN119613509A (zh) 2014-07-23 2025-03-14 奥克兰儿童医院及研究中心 因子h结合蛋白变体及其使用方法
BR122023020102A2 (pt) * 2014-08-20 2023-12-12 Stichting Sanquin Bloedvoorziening Anticorpos de potenciamento do fator h e seus usos
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
KR20210119397A (ko) 2018-12-21 2021-10-05 그리피스 유니버시티 면역 반응을 유도하기 위한 조성물, 방법 및 용도
EP3997108A4 (en) * 2019-07-08 2024-03-20 Crapaud Bio, Inc. METHODS OF PRODUCING AND USING LIPOOLIGOSACCHARIDE COMPOSITIONS AND VACCINES
CA3147638A1 (en) 2019-07-17 2021-01-21 Gemini Therapeutics Sub, Inc. Factor h potentiating antibodies and uses thereof
JP2024507828A (ja) 2021-02-19 2024-02-21 サノフィ パスツール インコーポレイテッド Ｂ群髄膜炎菌組換えワクチン
TW202423477A (zh) 2022-08-03 2024-06-16 美商賽諾菲巴斯德公司 針對腦膜炎奈瑟氏菌b的含佐劑免疫原性組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786592A (en) * 1986-06-18 1988-11-22 Scripps Clinic And Research Foundation Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin
US5476784A (en) * 1993-04-06 1995-12-19 Rice; Peter A. Gonococcal anti-idiotypic antibodies and methods and compositions using them
GB0220194D0 (en) * 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
US20070253964A1 (en) * 2003-04-16 2007-11-01 Zlotnick Gary W Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
US9034345B2 (en) * 2005-01-27 2015-05-19 Children's Hospital & Research Center Oakland GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
RU2450019C2 (ru) * 2006-06-29 2012-05-10 Новартис Аг Полипептиды из neisseria meningitidis
NZ598458A (en) * 2009-08-27 2014-03-28 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
BR112012024348B1 (pt) * 2010-03-30 2022-11-08 Children's Hospital & Research Center At Oakland Composição imunogênica, seu uso, proteína de ligação ao fator h de ocorrência não natural, e célula bacteriana geneticamente modificada

Also Published As

Publication number Publication date
HRP20240226T1 (hr) 2024-05-10
AU2009306114B2 (en) 2015-10-01
EP3501534B1 (en) 2023-11-29
DK3501534T5 (da) 2024-09-02
SI3501534T1 (sl) 2024-03-29
JP2015063558A (ja) 2015-04-09
CN102245202A (zh) 2011-11-16
EP3501534A1 (en) 2019-06-26
CN105412920A (zh) 2016-03-23
JP6076326B2 (ja) 2017-02-08
KR20110092282A (ko) 2011-08-17
DK3501534T3 (da) 2024-02-05
ES2970878T3 (es) 2024-05-31
WO2010046715A1 (en) 2010-04-29
PL3501534T3 (pl) 2024-04-02
NZ592444A (en) 2012-11-30
KR20170000390A (ko) 2017-01-02
CO6382140A2 (es) 2012-02-15
US20120052092A1 (en) 2012-03-01
LT3501534T (lt) 2024-03-12
PT3501534T (pt) 2024-02-07
JP2012506411A (ja) 2012-03-15
EP2355845B1 (en) 2018-12-05
HUE065348T2 (hu) 2024-05-28
KR20190011836A (ko) 2019-02-07
CA2741619A1 (en) 2010-04-29
EP2355845A1 (en) 2011-08-17
AU2009306114A1 (en) 2010-04-29
FI3501534T3 (fi) 2024-02-09
NZ601538A (en) 2014-01-31
JP5676458B2 (ja) 2015-02-25
RU2559528C2 (ru) 2015-08-10
RU2011120706A (ru) 2012-11-27
MX2011004322A (es) 2011-06-16
BRPI0919926A2 (pt) 2016-02-16

Similar Documents

Publication Publication Date Title
ZA201005268B (en) Composition
GB0815022D0 (en) Composition
GB0819633D0 (en) Composition
GB0822246D0 (en) Composition
GB0818473D0 (en) Composition
GB0810554D0 (en) Herbicde composition
GB0801119D0 (en) Composition
GB0818472D0 (en) Composition
GB0809808D0 (en) Composition
GB0811743D0 (en) Composition
GB0801401D0 (en) Composition
ZA201102726B (en) Composition
PL2128199T3 (pl) Nowa kompozycja
GB0810359D0 (en) Composition
GB0817656D0 (en) Composition
GB0812740D0 (en) Composition
GB0806948D0 (en) Composition
ZA201103080B (en) Composition
GB0818231D0 (en) Composition
GB0813589D0 (en) Composition
GB0809983D0 (en) Composition
GB0903681D0 (en) Composition
GB0823344D0 (en) Composition
GB0821754D0 (en) Composition
GB0820259D0 (en) Composition

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)